GPR30 is necessary for estradiol-induced desensitization of 5-HT 1A receptor signaling in the paraventricular nucleus of the rat hypothalamus

Psychoneuroendocrinology

Volumn 37, Issue 8, 2012, Pages 1248-1260

  McAllister, C E ^a   Creech, R D ^a   Kimball, P A ^a   Muma, N A ^a   Li, Q ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

5 HT 1A receptors; ACTH; Desensitization; Estradiol; GPER; GPR30; Oxytocin; Paraventricular nucleus; RGSz1

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADENOVIRUS VECTOR; ESTRADIOL BENZOATE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; MESSENGER RNA; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SMALL INTERFERING RNA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; GENE SILENCING; HORMONE RESPONSE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ESTRADIOL; FEMALE; GENE EXPRESSION; HEK293 CELLS; HUMANS; MODELS, BIOLOGICAL; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84862818880     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.12.018     Document Type: Article

References (89)

1. Acconcia F., Ascenzi P., Bocedi A., Spisni E., Tomasi V., Trentalance A., Visca P., Marino M. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol. Biol. Cell 2005, 16:231-237.
2. Albanito L., Madeo A., Lappano R., Vivacqua A., Rago V., Carpino A., Oprea T.I., Prossnitz E.R., Musti A.M., Ando S., Maggiolini M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67:1859-1866.
3. Alves S.E., Lopez V., McEwen B.S., Weiland N.G. Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3281-3286.
4. Archer D.F., Furst K., Tipping D., Dain M.P., Vandepol C. A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group. Obstet. Gynecol. 1999, 94:498-503.
5. Arpels J.C. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. J. Reprod. Med. 1996, 41:633-639.
6. Banger M. Affective syndrome during perimenopause. Maturitas 2002, 41(Suppl. 1):S13-S18.
7. Barr A.J., Brass L.F., Manning D.R. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor.G protein coupling. J. Biol. Chem. 1997, 272:2223-2229.
8. Bethea C.L., Smith A.W., Centeno M.L., Reddy A.P. Long-term ovariectomy decreases serotonin neuron number and gene expression in free ranging macaques. Neuroscience 2011, 192:675-688.
9. Birzniece V., Johansson I.M., Wang M.D., Seckl J.R., Backstrom T., Olsson T. Serotonin 5-HT(1A) receptor mRNA expression in dorsal hippocampus and raphe nuclei after gonadal hormone manipulation in female rats. Neuroendocrinology 2001, 74:135-142.
10. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 1994, 7:220-226.
11. Bollig A., Miksicek R.J. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol. 2000, 14:634-649.
12. Bosker F.J., Cremers T.I., Jongsma M.E., Westerink B.H., Wikstrom H.V., den Boer J.A. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala. J. Neurochem. 2001, 76:1645-1653.
13. Brailoiu E., Dun S.L., Brailoiu G.C., Mizuo K., Sklar L.A., Oprea T.I., Prossnitz E.R., Dun N.J. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol. 2007, 193:311-321.
14. Carrasco G.A., Barker S.A., Zhang Y., Damjanoska K.J., Sullivan N.R., Garcia F., D'Souza D., Muma N., van De Kar N.A.L.D. Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors. Neuroscience 2004, 127:261-267.
15. Chaput Y., de Montigny C., Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch. Pharmakol. 1986, 333:342-348.
16. Czachura J.F., Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch. Pharmakol. 2000, 362:266-275.
17. D'Souza D.N., Zhang Y., Damjanoska K.J., Carrasco G.A., Sullivan N.R., Garcia F., Battaglia G., Doncarlos L.L., Muma N.A., Van de Kar L.D. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats. Neuroendocrinology 2004, 80:31-41.
18. Dominguez R., Hu E., Zhou M., Baudry M. 17beta-estradiol-mediated neuroprotection and ERK activation require a pertussis toxin-sensitive mechanism involving GRK2 and beta-arrestin-1. J. Neurosci. 2009, 29:4228-4238.
19. Dominguez R., Micevych P. Estradiol rapidly regulates membrane estrogen receptor alpha levels in hypothalamic neurons. J. Neurosci. 2010, 30:12589-12596.
20. Filardo E.J. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor GPR30: a novel signaling pathway with potential significance for breast cancer. J. Steroid. Biochem. 2002, 80:231-238.
21. Filardo E.J., Graeber C.T., Quinn J.A., Resnick M.B., Giri D., DeLellis R.A., Steinhoff M.M., Sabo E. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin. Cancer Res. 2006, 6359-6366.
22. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
23. Freeman E.W., Sammel M.D., Liu L., Gracia C.R., Nelson D.B., Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch. Gen. Psychiatry 2004, 61:62-70.
24. Glick J.L., Meigs T.E., Miron A., Casey P.J. RGSZ1, a Gz-selective regulator of G protein signaling whose action is sensitive to the phosphorylation state of Gzalpha. J. Biol. Chem. 1998, 273:26008-26013.
25. Gomez-Gil E., Navines R., Martinez De Osaba M.J., Diaz-Ricart Ml, Escolar G., Salamero M., Martin-Santos R., Galan A., Gasto C. Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment. Psychoneuroendocrinology 2010, 35:481-489.
26. Gorosito S.V., Lorenzo A.G., Cambiasso M.J. Estrogen receptor alpha is expressed on the cell-surface of embryonic hypothalamic neurons. Neuroscience 2008, 154:1173-1177.
27. Gunther L., Liebscher S., Jahkel M., Oehler J. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. Eur. J. Pharmacol. 2008, 593:49-61.
28. Halbreich U. Gonadal hormones and antihormones, serotonin and mood. Psychopharmacol. Bull. 1990, 26:291-295.
29. Harlow B.L., Wise L.A., Otto M.W., Soares C.N., Cohen L.S. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch. Gen. Psychiatry 2003, 60:29-36.
30. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:2509-2514.
31. Henderson J.A., Bethea C.L. Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 2008, 33:285-293.
32. Hendricks T., Francis N., Fyodorov D., Deneris E.S. The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J. Neurosci. 1999, 19:10348-10356.
33. Hendricks T.J., Fyodorov D.V., Wegman L.J., Lelutiu N.B., Pehek E.A., Yamamoto B., Silver J., Weeber E.J., Sweatt J.D., Deneris E.S. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
34. Hrabovszky E., Kallo I., Steinhauser A., Merchenthaler I., Coen C.W., Petersen S.L., Liposits Z. Estrogen receptor-beta in oxytocin and vasopressin neurons of the rat and human hypothalamus: immunocytochemical and in situ hybridization studies. J. Comp. Neurol. 2004, 473:315-333.
35. Ishunina T.A., Swaab D.F. Estrogen receptor-alpha splice variants in the human brain. Gynecol. Endocrinol. 2008, 24:93-98.
36. Iyo A.H., Porter B., Deneris E.S., Austin M.C. Regional distribution and cellular localization of the ETS-domain transcription factor FEV, mRNA in the human postmortem brain. Synapse 2005, 57:223-228.
37. Jackson A., Uphouse L. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior. Horm. Behav. 1996, 30:145-152.
38. Jackson A., Uphouse L. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action. Brain Res. 1998, 796:299-302.
39. Jacobsen K.X., Czesak M., Deria M., Le Francois B., Albert P.R. Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo. J. Neurochem. 2011, 116:1066-1076.
40. Jia S., Zhang X., He D.Z., Segal M., Berro A., Gerson T.G., Wang Z., Casale T.B. Expression and function of a novel variant of estrogen receptor-ER-{alpha}36 in mouse airway. Am. J. Respir. Cell Mol. Biol. 2011, (June 3 Epub).
41. Jimerson D.C., Wolfe B.E., Metzger E.D., Finkelstein D.M., Cooper T.B., Levine J.M. Decreased serotonin function in bulimia nervosa. Arch. Gen. Psychiatry 1997, 54:529-534.
42. Joffe H., Cohen L.S. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?. Biol. Psychiatry 1998, 44:798-811.
43. Kang L., Zhang X., Xie Y., Tu Y., Wang D., Liu Z., Wang Z.Y. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 2010, 24:709-721.
44. Laflamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 1998, 36:357-378.
45. Lee L.M., Cao J., Deng H., Chen P., Gatalica Z., Wang Z.Y. ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas. Anticancer Res. 2008, 28:479-483.
46. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., Sequeira A., Kushwaha N., Morris S.J., Basak A., Ou X.M., Albert P.R. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 2003, 23:8788-8799.
47. Lerer B., Gelfin Y., Gorfine M., Allolio B., Lesch K.P., Newman M.E. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 1999, 20:628-639.
48. Lesch K.P. 5-HT1A receptor responsivity in anxiety disorders and depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 1991, 15:723-733.
49. Li L., Haynes M.P., Bender J.R. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4807-4812.
50. Li Q., Levy A.D., Cabrera T.M., Brownfield M.S., Battaglia G., Van de Kar L.D. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Res. 1993, 630:148-156.
51. Li Q., Muma N.A., Battaglia G., Van de Kar L.D. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J. Pharm. Exp. Ther. 1997, 282:1581-1590.
52. Li Q., Muma N.A., van de Kar L.D. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J. Pharm. Exp. Ther. 1996, 279:1035-1042.
53. Lomax P., Schonbaum E. Postmenopausal hot flushes and their management. Pharmacol. Ther. 1993, 57:347-358.
54. Lu N.Z., Bethea C.L. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002, 27:12-24.
55. Luo J., Deng Z.L., Luo X., Tang N., Song W.X., Chen J., Sharff K.A., Luu H.H., Haydon R.C., Kinzler K.W., Vogelstein B., He T.C. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc. 2007, 2:1236-1247.
56. Maggiolini M., Vivacqua A., Fasanella G., Recchia A.G., Sisci D., Pezzi V., Montanaro D., Musti A.M., Picard D., Ando S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 2004, 279:27008-27016.
57. Maurer P., Rorive S., de Kerchove d'Exaerde A., Schiffmann S.N., Salmon I., de Launoit Y. The Ets transcription factor Fev is specifically expressed in the human central serotonergic neurons. Neurosci. Lett. 2004, 357:215-218.
58. Mize A.L., Alper R.H. Acute and long-term effects of 17beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding. Brain Res. 2000, 859:326-333.
59. Navines R., Martin-Santos R., Gomez-Gil E., Martinez de Osaba M.J., Imaz M.L., Gasto C. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response. Psychoneuroendocrinology 2007, 32:411-416.
60. Nikisch G., Mathe A.A., Czernik A., Thiele J., Bohner J., Eap C.B., Agren H., Baumann P. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology 2005, 181:751-760.
61. Osei-Owusu P., James A., Crane J., Scrogin K.E. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. J. Pharm. Exp. Ther. 2005, 313:1324-1330.
62. Osterlund M.K., Hurd Y.L. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res. Mol. Brain Res. 1998, 55:169-172.
63. Patkar S., Farr T.D., Cooper E., Dowell F.J., Carswell H.V. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery. Neurosci. Res. 2011, 71:78-84.
64. Pecins-Thompson M., Bethea C.L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 1999, 89:267-277.
65. Raap D.K., DonCarlos L., Garcia F., Muma N.A., Wolf W.A., Battaglia G., Van de Kar L.D. Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z) G(i1) and G(i3) proteins in the hypothalamus. Neuropharmacology 2000, 39:1823-1832.
66. Raap D.K., Evans S., Garcia F., Li Q., Muma N.A., Wolf W.A., Battaglia G., Van De Kar L.D. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J. Pharm. Exp. Ther. 1999, 288:98-106.
67. Raymond J.R., Olsen C.L., Gettys T.W. Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha. Biochemistry 1993, 32:11064-11073.
68. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 2000, 12(Suppl. 1):2-19.
69. Revankar C.M, Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
70. Rivera H.M., Oberbeck D.R., Kwon B., Houpt T.A., Eckel L.A. Estradiol increases Pet-1 and serotonin transporter mRNA in the midbrain raphe nuclei of ovariectomized rats. Brain Res. 2009, 1259:51-58.
71. Rossi D.V., Dai Y., Thomas P., Carrasco G.A., DonCarlos L.L., Muma N.A., Li Q. Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-beta. Psychoneuroendocrinology 2010, 35:1023-1033.
72. Rush A.J., Fava M., Wisniewski S.R., Lavori P.W., Trivedi M.H., Sackeim H.A., Thase M.E., Nierenberg A.A., Quitkin F.M., Kashner T.M., Kupfer D.J., Rosenbaum J.F., Alpert J., Stewart J.W., McGrath P.J., Biggs M.M., Shores-Wilson K., Lebowitz B.D., Ritz L., Niederehe G. Sequenced treatment alternatives to relieve depression (STARD): rationale and design. Control. Clin. Trials 2004, 25:119-142.
73. Sakamoto H., Matsuda K., Hosokawa K., Nishi M., Morris J.F., Prossnitz E.R., Kawata M. Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei. Endocrinology 2007, 148:5842-5850.
74. Santoro N., Brown J.R., Adel T., Skurnick J.H. Characterization of reproductive hormonal dynamics in the perimenopause. J. Clin. Endocr. Metab. 1996, 81:1495-1501.
75. Sargent P., Williamson D.J., Pearson G., Odontiadis J., Cowen P.J. Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity. Psychopharmacology 1997, 132:296-302.
76. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Prog. Neurobiol. 2009, 88:17-31.
77. Schmidt P.J., Haq N., Rubinow D.R. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am. J. Psychiatry 2004, 161:2238-2244.
78. Schneider L.S., Small G.W., Hamilton S.H., Bystritsky A., Nemeroff C.B., Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am. J. Geriatr. Psychiatry 1997, 5:97-106.
79. Serres F., Li Q., Garcia F., Raap D.K., Battaglia G., Muma N.A., Van de Kar L.D. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo. J. Neurosci. 2000, 20:3095-3103.
80. Shively C.A., Bethea C.L. Cognition, mood disorders, and sex hormones. ILAR J. 2004, 45:189-199.
81. Simonian S.X., Herbison A.E. Differential expression of estrogen receptor alpha and beta immunoreactivity by oxytocin neurons of rat paraventricular nucleus. J. Neuroendocrinol. 1997, 9:803-806.
82. Szewczyk B., Albert P.R., Burns A.M., Czesak M., Overholser J.C., Jurjus G.J., Meltzer H.Y., Konick L.C., Dieter L., Herbst N., May W., Rajkowska G., Stockmeier C.A., Austin M.C. Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int. J. Neuropsychopharmacol. 2009, 12:155-168.
83. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
84. Wang J., Ducret A., Tu Y., Kozasa T., Aebersold R., Ross E.M. RGSZ1, a Gz-selective RGS protein in brains Structure, membrane association, regulation by Galphaz phosphorylation, and relationship to a Gz gtpase-activating protein subfamily. J. Biol. Chem. 1998, 273:26014-26025.
85. Wang Y., Ho G., Zhang J.J., Nieuwenhuijsen B., Edris W., Chanda P.K., Young K.H. Regulator of G protein signaling Z1 (RGSZ1) interacts with Galpha i subunits and regulates Galpha i-mediated cell signaling. J. Biol. Chem. 2002, 277:48325-48332.
86. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem. Biophys. Res. Commun. 2005, 336:1023-1027.
87. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9063-9068.
88. Xu H., Qin S., Carrasco G.A., Dai Y., Filardo E.J., Prossnitz E.R., Battaglia G., Doncarlos L.L., Muma N.A. Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience 2009, 158:1599-1607.
89. Zou Y., Ding L., Coleman M., Wang Z. Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36. FEBS Lett. 2009, 583:1368-1374.